• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

额颞叶变性患者脑脊液中的 tau:临床、神经影像学和预后相关因素。

Cerebrospinal fluid tau in frontotemporal lobar degeneration: clinical, neuroimaging, and prognostic correlates.

机构信息

The Centre for Ageing Brain and Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy.

出版信息

J Alzheimers Dis. 2011;23(3):505-12. doi: 10.3233/JAD-2010-101407.

DOI:10.3233/JAD-2010-101407
PMID:21098973
Abstract

Frontotemporal lobar degeneration (FTLD) refers to heterogeneous clinical and biological conditions. In FTLD, cerebrospinal fluid (CSF) tau levels have been reported highly variable. The aim of the present study was to evaluate whether CSF tau might be the hallmark of a distinct FTLD phenotype. Fifty-five FTLD patients, who underwent CSF analysis, were considered in the present study. In each patient, a wide standardized neuropsychological evaluation, and CSF tau, phospho-tau, and amyloid-β (Aβ) dosages were performed. Each patient was followed-up to five years, and outcomes carefully recorded. In a subgroup of patients (n = 24), magnetic resonance imaging scanning was performed, by using voxel-based morphometry, for grey matter investigation. The higher the CSF tau levels, the worse the neuropsychological and neuroimaging pattern, mainly characterized by greater language disturbances and left temporal grey matter loss. The same pattern, even if less significant, was associated with CSF phospho-tau, while CSF Aβ levels did not play any influence on FTLD phenotype. FTLD patients with high CSF tau showed poor prognosis compared to those with low CSF tau (p = 0.031). In FTLD, CSF tau levels might be considered a marker of neurodegeneration, associated with a specific clinical and neuroimaging picture, and significantly related to poor outcome. Further studies aimed at defining the biological underpinnings of these findings are warranted.

摘要

额颞叶变性(FTLD)是指异质性的临床和生物学条件。在 FTLD 中,脑脊液(CSF)中的 tau 水平被报道存在高度变异性。本研究旨在评估 CSF tau 是否可能是独特 FTLD 表型的标志。本研究共纳入了 55 名接受 CSF 分析的 FTLD 患者。每位患者均进行了广泛的标准化神经心理学评估,以及 CSF tau、磷酸化 tau 和淀粉样蛋白-β(Aβ)的检测。每位患者均进行了长达五年的随访,并仔细记录了结果。在一组患者(n = 24)中,通过基于体素的形态计量学进行了磁共振成像扫描,以进行灰质研究。CSF tau 水平越高,神经心理学和神经影像学模式越差,主要表现为更严重的语言障碍和左侧颞叶灰质丢失。即使不太明显,与 CSF 磷酸化 tau 相关的也是相同模式,而 CSF Aβ 水平对 FTLD 表型没有任何影响。与 CSF tau 水平较低的患者相比,CSF tau 水平较高的 FTLD 患者预后较差(p = 0.031)。在 FTLD 中,CSF tau 水平可能被视为神经退行性变的标志物,与特定的临床和神经影像学表现相关,并与不良结局显著相关。需要进一步研究来确定这些发现的生物学基础。

相似文献

1
Cerebrospinal fluid tau in frontotemporal lobar degeneration: clinical, neuroimaging, and prognostic correlates.额颞叶变性患者脑脊液中的 tau:临床、神经影像学和预后相关因素。
J Alzheimers Dis. 2011;23(3):505-12. doi: 10.3233/JAD-2010-101407.
2
Cerebrospinal fluid biomarkers in Progranulin mutations carriers.携带颗粒蛋白前体突变者的脑脊液生物标志物。
J Alzheimers Dis. 2011;27(4):781-90. doi: 10.3233/JAD-2011-111046.
3
Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjects.脑脊液 Aβ40 水平对 FTLD 与对照组的鉴别诊断具有附加价值。
J Alzheimers Dis. 2010;20(2):445-52. doi: 10.3233/JAD-2010-1392.
4
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.脑脊液 tau、神经丝和颗粒蛋白在明确的额颞叶变性中的诊断价值。
Alzheimers Res Ther. 2018 Mar 20;10(1):31. doi: 10.1186/s13195-018-0364-0.
5
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.脑脊液生物标志物谱在额颞叶痴呆中的诊断价值
Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):47-53. doi: 10.1097/WAD.0b013e3181610fea.
6
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.额颞叶痴呆和阿尔茨海默病的脑脊液特征
Ann Neurol. 2005 May;57(5):721-9. doi: 10.1002/ana.20477.
7
Genetic background predicts poor prognosis in frontotemporal lobar degeneration.遗传背景预示额颞叶变性预后不良。
Neurodegener Dis. 2011;8(5):289-95. doi: 10.1159/000322790. Epub 2011 Feb 11.
8
Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum.在阿尔茨海默病连续体中,脑脊液 tau 与脑萎缩之间的关联与临床严重程度无关。
Psychiatry Res. 2011 Jun 30;192(3):140-6. doi: 10.1016/j.pscychresns.2010.12.001. Epub 2011 May 4.
9
Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.与TDP-43蛋白相比,tau蛋白是额颞叶痴呆亚型潜在的脑脊液生物标志物:一项初步研究。
J Alzheimers Dis. 2017;55(2):585-595. doi: 10.3233/JAD-160386.
10
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia.脑脊液中磷酸化tau蛋白181/总tau蛋白比值作为额颞叶痴呆中TDP病理改变的生物标志物
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):86-91. doi: 10.3109/21678421.2014.971812. Epub 2014 Oct 29.

引用本文的文献

1
Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic review.脑脊髓液标志物与衰老和痴呆认知的关联:系统综述。
Eur J Neurosci. 2022 Nov;56(9):5650-5713. doi: 10.1111/ejn.15656. Epub 2022 May 12.
2
Biomarkers in Alzheimer's, Frontotemporal, Lewy Body, and Vascular Dementias.阿尔茨海默病、额颞叶痴呆、路易体痴呆和血管性痴呆中的生物标志物。
Focus (Am Psychiatr Publ). 2018 Apr;16(2):164-172. doi: 10.1176/appi.focus.20170048. Epub 2018 Apr 27.
3
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.
额颞叶痴呆的生物学、神经影像学和神经生理学标志物:同一枚硬币的三面。
J Alzheimers Dis. 2018;62(3):1113-1123. doi: 10.3233/JAD-170584.
4
Biomarkers in dementia: clinical utility and new directions.痴呆症中的生物标志物:临床应用及新方向。
J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1426-34. doi: 10.1136/jnnp-2014-307662. Epub 2014 Sep 26.